Medicare Enrolled
Dr. Sasha Davis, MD
Internal Medicine · Tyler, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Davis from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Davis?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Davis
Dr. Sasha Davis is an internal medicine specialist in Tyler, TX, with 14 years of NPI registration. Based on federal Medicare data, Dr. Davis performed 88,902 Medicare services across 3,705 unique beneficiaries.
Between the years covered by Open Payments, Dr. Davis received a total of $5,024 from 52 pharmaceutical and/or device companies across 143 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Davis is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 14 years in practice
▲ Top 1% volume in TX
$5,024 industry payments
Medicare Practice Summary
Medicare Utilization ↗88,902
Medicare services
Top 1% in TX for internal medicine
3,705
Unique beneficiaries
$14
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~6,350 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 17,850 | $0 | $5 |
| Oxaliplatin chemotherapy injection | 9,740 | $0 | $33 |
| Pembrolizumab injection (Keytruda) | 9,000 | $44 | $137 |
| Nivolumab injection (Opdivo) | 8,140 | $24 | $77 |
| Darbepoetin injection (Aranesp) for anemia | 7,070 | $2 | $20 |
| Paclitaxel chemotherapy injection | 6,702 | $0 | $8 |
| Daratumumab injection (Darzalex) | 5,940 | $38 | $128 |
| Contrast dye for imaging (iodine-based) | 5,790 | $0 | $3 |
| Iron sucrose injection (Venofer) | 4,500 | $0 | $2 |
| Dexamethasone injection (steroid) | 2,031 | $0 | $1 |
| Immune globulin infusion (Octagam) | 1,540 | $34 | $235 |
| Denosumab injection (Prolia/Xgeva) | 1,140 | $18 | $67 |
| Injection, granisetron hydrochloride, 100 mcg | 800 | $0 | $24 |
| Blood draw (venipuncture) | 756 | $8 | $20 |
| Complete blood count (CBC) with differential | 622 | $7 | $36 |
| Comprehensive metabolic blood panel | 561 | $10 | $64 |
| Injection of additional new drug or substance into vein | 461 | $12 | $108 |
| Anti-nausea injection (Aloxi/palonosetron) | 340 | $1 | $114 |
| Injection, leucovorin calcium, per 50 mg | 321 | $3 | $25 |
| Administration of chemotherapy into vein, 1 hour or less | 304 | $98 | $707 |
| Injection, fluorouracil, 500 mg | 302 | $2 | $13 |
| Office visit, established patient (20-29 min) | 281 | $62 | $250 |
| Office visit, established patient (30-39 min) | 273 | $88 | $368 |
| Injection, carboplatin, 50 mg | 259 | $2 | $300 |
| Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | 249 | $272 | $2,762 |
| Lactate dehydrogenase (enzyme) level | 209 | $6 | $31 |
| Immunoglobulin level test | 199 | $9 | $56 |
| Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 180 | $79 | $1,348 |
| Injection, zoledronic acid, 1 mg | 172 | $6 | $431 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 172 | $3 | $373 |
| Injection, potassium chloride, per 2 meq | 160 | $0 | $1 |
| Injection, gemcitabine hydrochloride (accord), not therapeutically equivalent to j9201, 200 mg | 156 | $3 | $28 |
| Magnesium level test | 153 | $6 | $29 |
| Office visit, established patient, complex (40-54 min) | 137 | $132 | $496 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 132 | $22 | $157 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 124 | $48 | $313 |
| Microscopic examination for white blood cells with manual cell count | 115 | $4 | $22 |
| Complete blood count (CBC), automated | 115 | $6 | $34 |
| Injection, cisplatin, powder or solution, 10 mg | 111 | $2 | $94 |
| Injection, magnesium sulfate, per 500 mg | 102 | $1 | $6 |
| Administration of additional new drug or substance into vein, 1 hour or less | 101 | $48 | $344 |
| Reticulated (young) platelet measurement | 100 | $35 | $143 |
| Injection, diphenhydramine hcl, up to 50 mg | 95 | $1 | $7 |
| Drug injection, under skin or into muscle | 91 | $11 | $96 |
| Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services | 90 | $69 | $70 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 87 | $55 | $211 |
| Ferritin level test (iron stores) | 84 | $13 | $60 |
| Iron level test | 77 | $6 | $27 |
| Iron binding capacity test | 77 | $9 | $35 |
| Administration of chemotherapy into vein, each additional hour | 73 | $21 | $161 |
| Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | 70 | $335 | $1,722 |
| Phosphate level test | 62 | $4 | $24 |
| Ct scan of chest with contrast | 55 | $50 | $821 |
| Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19 mev | 55 | $178 | $700 |
| Office visit, established patient (10-19 min) | 49 | $34 | $150 |
| Unclassified drugs | 49 | $1 | $8 |
| Infusion, normal saline solution , 1000 cc | 45 | $2 | $19 |
| Basic metabolic blood panel | 36 | $8 | $49 |
| Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | 33 | $124 | $500 |
| CT scan of abdomen and pelvis with contrast | 31 | $165 | $1,067 |
| New patient office visit (45-59 min) | 30 | $123 | $565 |
| Irrigation of implanted venous access drug delivery device | 29 | $19 | $114 |
| Carcinoembryonic antigen (cea) protein level | 25 | $19 | $99 |
| Red blood count, automated test | 25 | $4 | $23 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 25 | $15 | $94 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 24 | $16 | $100 |
| Administration of additional new drug or substance into vein using push technique | 22 | $42 | $289 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 22 | $1 | $19 |
| Infusion into a vein for hydration, 31-60 minutes | 20 | $25 | $256 |
| Infusion into a vein for hydration, each additional hour | 19 | $10 | $75 |
| PSA test (prostate cancer screening) | 18 | $18 | $94 |
| Initial hospital admission, moderate complexity | 18 | $94 | $470 |
| Manual urinalysis test with examination using microscope, non-automated | 17 | $4 | $26 |
| Application of on-body injector for under skin injection | 15 | $14 | $96 |
| Ct scan of abdomen and pelvis before and after contrast | 12 | $198 | $1,413 |
| New patient office visit (30-44 min) | 12 | $78 | $372 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
22.3% high complexity
72.5% medium
5.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$5,024
Total received (2018-2024)
Avg $718/year across 7 years
Top 16% in TX for internal medicine
52
Companies
143
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,788 (95.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$236 (4.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,344
2023
$1,071
2022
$557
2021
$358
2020
$209
2019
$389
2018
$1,096
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$356
Rigel Pharmaceuticals, Inc.
$334
AstraZeneca Pharmaceuticals LP
$290
Novartis Pharmaceuticals Corporation
$282
Myriad Genetic Laboratories, Inc.
$219
Karyopharm Therapeutics Inc.
$216
GENZYME CORPORATION
$208
Celgene Corporation
$196
ABBVIE INC.
$179
Kite Pharma, Inc.
$160
Tempus AI, Inc
$159
Exelixis Inc.
$141
Seagen Inc.
$129
Puma Biotechnology, Inc.
$125
Eisai Inc.
$124
Janssen Scientific Affairs, LLC
$113
Blueprint Medicines Corporation
$112
Pharmacosmos Therapeutics Inc.
$102
EISAI INC.
$101
Incyte Corporation
$96
Ipsen Biopharmaceuticals, Inc
$96
Lilly USA, LLC
$94
TAIHO ONCOLOGY, INC.
$93
BeiGene USA, Inc.
$90
SANOFI-AVENTIS U.S. LLC
$85
Novocure Inc.
$82
Pharmacyclics LLC, An AbbVie Company
$76
Regeneron Healthcare Solutions, Inc.
$71
PUMA BIOTECHNOLOGY, INC.
$66
Janssen Biotech, Inc.
$64
E.R. Squibb & Sons, L.L.C.
$63
GlaxoSmithKline, LLC.
$57
Daiichi Sankyo Inc.
$53
Takeda Pharmaceuticals U.S.A., Inc.
$37
Boston Scientific Corporation
$33
Merck Sharp & Dohme LLC
$32
Aveo Pharmaceuticals, Inc.
$28
Tactile Systems Technology Inc
$25
G1 Therapeutics, Inc.
$25
Amgen Inc.
$20
CTI BioPharma Corp.
$20
Bayer HealthCare Pharmaceuticals Inc.
$19
JAZZ PHARMACEUTICALS INC.
$19
Shire North American Group Inc
$19
Boehringer Ingelheim Pharmaceuticals, Inc.
$19
MorphoSys, US Inc.
$18
AbbVie Inc.
$16
Emmaus Medical, Inc.
$14
TESARO, Inc.
$14
Janssen Pharmaceuticals, Inc
$14
Gilead Sciences, Inc.
$12
ARRAY BIOPHARMA INC
$10
Top 3 companies account for 19.5% of total payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · AYVAKIT · BOSULIF · BRAFTOVI · BRUKINSA · CALQUENCE · COSELA · CYRAMZA · Cabometyx · ELIQUIS · ELREXFIO · ENHERTU · EPKINLY · Endari · EndoPredict · Erleada · FOTIVDA · Flexitouch Plus · IBRANCE · IMBRUVICA · JAKAFI · JEMPERLI · KEYTRUDA · KISQALI · Kyprolis · LIBTAYO · LONSURF · LUTATHERA · LYNPARZA · Lenvima · MONJUVI · MONOFERRIC · MYRISK · NERLYNX · NINLARO · Nerlynx · OPDIVO · Oncology · Onivyde · PADCEV · PIQRAY · PLUVICTO · Revlimid · Rezlidhia · SARCLISA · SOMATULINE DEPOT · SPRYCEL · SUTENT · Stivarga · TABRECTA · TAGRISSO · TECVAYLI · TUKYSA · Tavalisse · VERZENIO · VPRIV · VYXEOS · Vonjo · WATCHMAN Access System · XALKORI · XARELTO · XPOVIO · XT CDX · Yescarta · ZEJULA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (95%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $6 per 100 Medicare services performed
Geographic Context
Internal medicine physicians within 10 mi
170
Per 100K population
71.4
County median income
$71,923
Nearest hospital
UT HEALTH EAST TEXAS TYLER REGIONAL HOSPITAL
3.0 mi
3.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Davis is a mixed practice specialist, with above-average Medicare volume (top 1% in TX), with low-engagement industry engagement in the top 16% of TX peers.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Davis experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Davis performed 17,850 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Davis receive payments from pharmaceutical companies?
Yes. Dr. Davis received a total of $5,024 from 52 companies across 143 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Davis's costs compare to other internal medicine physicians in Tyler?
Dr. Davis's average Medicare payment per service is $14. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Davis) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Tyler
Browse internal medicine physicians in Tyler ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in TX
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in TX
Which TX internal medicine physicians receive the most from drug and device companies.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Rigel Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Rigel Pharmaceuticals, Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology